大剂量叶酸对介入治疗后的冠心病患者血管内皮功能的影响The effects of high-dose folic acid on vascular endothelial function in patients with coronary artery disease and undergone interventional therapy
李卫虹,冯新恒,王广,孙威,李昭屏,金楠,毛节明
摘要(Abstract)：
目的探讨大剂量叶酸能否改善冠心病患者介入治疗后的血管内皮功能。方法共46例冠心病患者,在行冠状动脉介入治疗术后分为叶酸治疗(20mg/d)组23例和对照组23例,随访6个月,观察两组间同型半胱氨酸水平,以超声测定肱动脉血流介导的舒张功能(FMD)变化来评价血管内皮功能,并观察两组间的差别。结果大剂量叶酸治疗组血浆同型半胱氨酸水平低于对照组(8·82±3·32μmol/L比12·67±3·07μmol/L,P<0·01)。叶酸治疗后FMD由4·70%±1·71%增加至8·53%±1·44%(P<0·01)。结论大剂量叶酸治疗可能通过降低同型半胱氨酸以外的途径改善血管内皮功能,对介入治疗后的冠心病患者发挥潜在益处。
关键词(KeyWords)： 冠状动脉疾病;内皮,血管;叶酸
基金项目(Foundation):
作者(Author): 李卫虹,冯新恒,王广,孙威,李昭屏,金楠,毛节明
参考文献(References)：
- [1]Woo KS,Chook P,Lolin YI,et al.Hyperhomocyst(e)inemia is a riskfactorfor arterial endothelial dysfunctionin humans.Circulation,1997,96:2542-2544.
- [2]Celemajer DS,Sorensen KE,Gooch VM,et al.Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis.Lancet,1992,340:1111-1115.
- [3]Clark R,Daly L,Robinson K,et al.Hyperhomocystemia:an independent risk factor for varscular disease.N Eng J Med,1991,324:1149-1155.
- [4]Woo KS,Chook P,Lolin YI,Cheung AS,et al.Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction inhumans.Circulation,1997,96:2542-2544.
- [5]Homocysteine-lowering Trialists’Collaboration.Lowering blood homocysteine with folic acid based supplements.Br Med J,1998,316:894-898.
- [6]Doshi SN,Mcdowell FW,Moat SJ,et al.Folic acid improve endothelial functionin coronary artery disease via mechanisms largely independent of homocysteine lowering.Cirulation,2002,105:22-26.
- [7]Verhaar MC,Wever RMF,Kastelein JJP,et al.5-Methyltertrahydrofoalte,the active form of folic acid,improves endothelial function in familial hypercholesterolemia.Circulation,1998,97:237-241.
- [8]Doshi SN,McDowell IF,Moat SJ,et al.Folate improves endothelial functionin coronary artery disease:an effect mediated byreduction of intracellular superoxide?Arterioscler Thromb Vasc Boil,2001,21:1196-1201.
- [9]Stroes ESG,van Faassen EE,Yo M,et al.Folic acid reverts dysfunction of endothelialnitric oxide synthase.Circ Res,2000,86:1129-1134.
- [10]Wang G,Dai J,Mao JM,et al.Folic acid reverses hyper-responsiveness of LPS-induced chemokine secretionfrommonocytesin patients with hyperhomocysteinemia.Atherosclerosis,2005,179:395-402.
- [11]Piero O,Bonetti,Lilach O,et al.Endothelial dysfunction a marker of atherosclerotic risk.Arterioscler Thromb Vasc Biol,2003,23:168-175.